Abraham Spector - New York NY Stephen R. Wilson - Chatham NJ Paul A. Zucker - Maplewood NJ
Assignee:
The Trustees of Columbia University in the City of New York - New York NY New York University - New York NY
International Classification:
C07C 3702 A01K 31095
US Classification:
546224
Abstract:
The present invention provides compounds having glutathione peroxidase activity and, therefore, are effective glutathione peroxidase replacements. These compounds are useful as drugs for the prevention of cataracts and as anti-oxidants for H. sub. 2 O. sub. 2 and other peroxides. The present invention also provides methods and pharmaceutical compositions of the compound.
Use Of Heme-Peptides To Prevent Or Retard Disease Associated With Oxidative Stress
Abraham Spector - New York NY Wanchao Ma - New York NY
Assignee:
The Trustees of Columbia University in the City of New York - New York NY
International Classification:
A61K 3800 A61K 3816 C07K 500 C07K 700
US Classification:
514 6
Abstract:
This invention provides a method for treating a condition associated with oxidative stress in a subject which comprises administering to the subject an amount of a heme-peptide effective to treat the condition associated with oxidative stress in the subject. The subject may be a mammal. The mammal may be a human being. The condition associated with oxidative stress may be an inflammatory condition, an allergic condition or an auto-immune condition.
Compounds Having Glutathione Peroxidase Activity And Use Thereof
Abraham Spector - New York NY Stephen R. Wilson - Chatham NJ Paul A. Zucker - Maplewood NJ
Assignee:
The Trustees of Columbia University in the City of New York - New York NY New York University - New York NY
International Classification:
C07C40312 C07D31902 A61K 3140 A61K 31095
US Classification:
514422
Abstract:
The present invention provides compounds having glutathione peroxidase activity and, therefore, are effective glutathione peroxidase replacements. These compounds are useful as drugs for the prevention of cataracts and as anti-oxidants for H. sub. 2 O. sub. 2 and other peroxides. The present invention also provides methods and pharmaceutical compositions of the compound.
Method And Ophthalmic Composition For The Prevention And Reversal Of Cataracts
Vincent P. Pigiet - Winchester MA Abraham Spector - New York NY
Assignee:
Trustees of Columbia University in the city of New York - New York NY
International Classification:
A61K 3702
US Classification:
514 17
Abstract:
The subject invention concerns a process for the prevention and reversal of cataracts. Specifically, the invention comprises the treatment of the eye lens with an effective cataract inhibiting amount of thioredoxin or thioredoxin-derived, or thioredoxin-like, dithiol peptide, alone, or in combination with a thioredoxin reductase regenerating system. The thioredoxin compound can be administered topically to a patient in need of such treatment on a daily basis over an extended period of time via known delivery techniques such as eye drops and ocular inserts.